Skip to main content
. 2021 Mar 21;9(3):319. doi: 10.3390/biomedicines9030319

Table 1.

Overview of 2016 World Health Organization (WHO) classification system for grading meningiomas. HPF, high-power fields; N/C, nuclear/cytoplasmic.

Grade I Grade II Grade III
Histologic Subtypes Meningothelial
Fibrous
Transitional
Psammomatous
Angiomatous
Microcystic
Secretory
Lymphoplasmacyte-rich
Metaplastic
Atypical
Clear cell
Choroid
Anaplastic
Rhabdoid
Papillary
Diagnostic Criteria -Presence of <4 mitoses per 10 HPF -Presence of 4–19 mitoses per 10 HPF
or
-Brain invasion
or
-At least 3/5 of the following:
-Patternless sheeting architecture
-Small cell formation with high N/C ratio
-Prominent nucleoli
-Hypercellularity
-Spontaneous intratumoral micronecrosis
-Presence of ≥20 mitoses per 10 HPF
or
-Overtly malignant morphology (carcinomatous, sarcomatous, and melanomatous cytology)